000 01395 a2200373 4500
005 20250512080853.0
264 0 _c19851017
008 198510s 0 0 eng d
022 _a0022-1007
024 7 _a10.1084/jem.162.3.1105
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRanges, G E
245 0 0 _aPrevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.
_h[electronic resource]
260 _bThe Journal of experimental medicine
_cSep 1985
300 _a1105-10 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAnimals
650 0 4 _aAntibodies, Monoclonal
_ximmunology
650 0 4 _aAntigens, Differentiation, T-Lymphocyte
650 0 4 _aAntigens, Surface
_ximmunology
650 0 4 _aArthritis
_xchemically induced
650 0 4 _aAutoantibodies
_xanalysis
650 0 4 _aAutoimmune Diseases
_xchemically induced
650 0 4 _aCollagen
_ximmunology
650 0 4 _aH-2 Antigens
_ximmunology
650 0 4 _aImmunoglobulin G
_xanalysis
650 0 4 _aMale
650 0 4 _aMice
650 0 4 _aMice, Inbred DBA
_ximmunology
700 1 _aSriram, S
700 1 _aCooper, S M
773 0 _tThe Journal of experimental medicine
_gvol. 162
_gno. 3
_gp. 1105-10
856 4 0 _uhttps://doi.org/10.1084/jem.162.3.1105
_zAvailable from publisher's website
999 _c3934489
_d3934489